Aethlon Medical, Inc. (AEMD)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 20, 2025

$1.58

P/E Ratio

N/A

Market Cap

$3.18M

Description
Add to research
View more

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

Metrics
Add to research
View more

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerAEMD
  • Price$1.58-9.20%

Trading Information

  • Market cap$3.18M
  • Float93.91%
  • Average Daily Volume (1m)146,238
  • Average Daily Volume (3m)128,466
  • EPS-$12.75

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$1.75M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$1.73M
  • EV$7.91M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.64
  • Debt/Equity16.72
Documents
Add to research
View more